Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

NCT00144339

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.235.3779 Boehringer Ingelheim Investigational Site Anniston, Alabama, United States
  • 205.235.3785 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.235.3804 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 205.235.3795 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
View all 490 locations
View Trial Details
Completed

Tiotropium Respimat Pharmacokinetic Study in COPD

NCT01222533

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.458.32003 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 205.458.32001 Boehringer Ingelheim Investigational Site Ghent, Belgium
  • 205.458.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 205.458.45001 Boehringer Ingelheim Investigational Site Copenhagen K, Denmark
View Trial Details
Completed

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.

NCT00359788

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.325.904 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.325.925 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 205.325.909 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
  • 205.325.912 Boehringer Ingelheim Investigational Site Long Beach, California, United States
View all 31 locations
View Trial Details
Completed

Tiotropium and Salmeterol PK Study in COPD Patients

NCT00673478

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1184.24.32001 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 1184.24.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 1184.24.31001 Boehringer Ingelheim Investigational Site Heerlen, Netherlands
View Trial Details
Completed

Tiotropium / Respimat One Year Study in COPD.

NCT00387088

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.372.01012 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.372.01020 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.372.01062 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 205.372.01048 Boehringer Ingelheim Investigational Site Berkeley, California, United States
View all 334 locations
View Trial Details
Completed

Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region

NCT01006135

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site 1 Drniš, Croatia
  • Boehringer Ingelheim Investigational Site 2 Ivani? Grad-Zagreb, Croatia
  • Boehringer Ingelheim Investigational Site 3 Karlovac, Croatia
  • Boehringer Ingelheim Investigational Site 4 Knin, Croatia
View all 864 locations
View Trial Details
Completed

Observational Non-Interventional Study With Spiriva Respimat in COPD Patients

NCT00699699

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Aachen, Germany
  • Boehringer Ingelheim Investigational Site Amberg, Germany
  • Boehringer Ingelheim Investigational Site Auerbach, Germany
  • Boehringer Ingelheim Investigational Site 1 Augsburg, Germany
View all 188 locations
View Trial Details

Related conditions